【摘要】 目的:探讨临床路径管理在急性脑梗死治疗中的实施效果及应用价值。方法:采用回顾性队列研究的方式比较临床路径实施前后(2011年6月)急性脑梗死患者的相关情况,主要评价指标包括住院费用、疾病特征、诊疗质量等。结果:路径组的平均住院总费用、药费、检查费、床位费和平均住院天数均少于对照组,差异有统计学意义(P<0.05);而在手术费、治疗费和其他费用在路径组和对照组之间差异无统计学意义(P>0.05)。患者治疗效果比较发现,路径组的治愈率相较对照组更高,但两组治疗效果之间总体差异无统计学意义(P>0.05);路径组患者住院并发症发生率低于对照组,差异有统计学意义(P<0.05);两组之间病死率差异无统计学意义(P>0.05);两组患者入院与出院诊断符合率均为100%。结论:急性脑梗死临床路径管理可以缩短平均住院日、降低住院费用、提高诊疗质量,值得进一步推广。更多还原

【Abstract】 Objective: To evaluate the effects of the clinical path management in the treatment of acute cerebral infarction. Methods: A retrospective cohort study was applied to compare the status between the control group and the path group,the main evaluation indicators included hospital costs,disease characteristics,treatment quality.Results: Total cost of hospitalization,drugs fees,inspection fees,bed charges and the average hospitalization days in path group were less than those in the control group,the differences were statistically significant( P < 0. 05);while in surgery,treatment costs and other expenses had no statistically significant differences between two groups( P >0. 05). The cure rate in path group was higher than that in the control group,but the overall difference between two groups was not statistically significant( P > 0. 05); hospitalization incidence of complications in path group was higher than that in the control group( P < 0. 05); mortality between the two groups showed no significant difference( P > 0. 05); the diagnosis compatibility rate of patients discharged from hospital was 100%.Conclusion: Acute cerebral infarction path management can shorten the average length of stay,reduce hospital costs and improve quality of care,worthy of further promotion.更多还原